Reports showed that upregulation of PD-L1 in CRC cells is associated with poorly differentiated and solid/medullary histology, MSI-H or dMMR, and BRAF mutations [95, 97, 98], signatures of the serrated neoplasia pathway of colorectal adenocarcinomas [99]. The gene discussed is BRAF; the disease is colorectal carcinoma.